By: Mark S. Bergman , Paul, Weiss, Rifkind, Wharton & Garrison LLP Introduction This article discusses the joint Public Statement 1 issued by the U.S. Securities and Exchange Commission (the SEC) Chairman Jay Clayton, SEC Division of Corporation...

By: Janet B. Linn , Tarter Krinsky & Drogin LLP This article addresses how counsel for a generic drug company should prepare for patent litigation under the Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch...

By: Christopher Donovan , Heidi Jeffery , Nathaniel Lacktman , and Melesa Freerks , Foley & Lardner LLP THIS ARTICLE ASSESSES THE CHARACTERISTICS OF THE digital health industry and examines whether the market is ripe for notable private equity investment...

By: Winston Penhall , Reed Smith LLP This article addresses common questions and concerns regarding the marketing of alternative investment funds in the European Economic Area (EEA), should a “hard Brexit” occur. Hard Brexit is a scenario...

By: Aravind Swaminathan , David T. Cohen , Rochelle Swartz , and Nicholas Farnsworth Orrick Herrington & Sutcliffe LLP A recent decision from the Supreme Court of Illinois heightens the risks faced by companies collecting biometric information by...